Guggenheim Russell Top 50® Mega Cap ETF

Most Recent

  • uploads///Chart  Diabetes
    Company & Industry Overviews

    Merck & Co.’s Diabetes Products in 3Q17

    The combined revenues for Januvia and Janumet decreased 2% at constant exchange rates to $1.52 billion in 3Q17 compared to $1.55 billion in 3Q16.

    By Mike Benson
  • uploads///Chart
    Company & Industry Overviews

    Johnson & Johnson’s Pharmaceutical Business Performance in 3Q17

    JNJ’s pulmonary hypertension products were acquired from Actelion in 2Q17 and reported revenues of $670.0 million during 3Q17.

    By Mike Benson
  • uploads///Chart
    Company & Industry Overviews

    What Contributed to Pfizer’s Growth in 2016?

    The key performers of Pfizer’s product portfolio include Lyrica, Ibrance, Xeljanz, and Eliquis from the Innovative Health business.

    By Mike Benson
  • uploads///globalization
    Company & Industry Overviews

    How Is Medtronic’s Globalization Strategy Driving Its Growth?

    Medtronic’s (MDT) growth is driven by three of the company’s core strategies—therapy innovation, globalization, and economic value.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.